Why Pacira BioSciences Stock Is Having Its Best Day Ever After $1.7 Billion Viatris Acquisition Why Pacira BioSciences Stock Is Having Its Best Day Ever After $1.7 Billion Viatris Acquisition · Barrons.com · Dreamstime Mackenzie Tatananni October 8, 2026 3 min read VTRS PCRX LLY VRTX IHE Viatris has agreed to acquire Pacira BioXciences, acquiring its portfolio of non-opioid pain medications. Continue Reading Terms and Privacy Policy Your Privacy Choices More Info